Unusual reactivity of cisplatin analogs that bear o-phenylenediamine ligands: Insights for the design of more effective cytotoxic agents

Journal of Inorganic Biochemistry

Volumn 62, Issue 4, 1996, Pages 281-298

  Köckerbauer, Reinhold ^a   Bednarski, Patrick J ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; CISPLATIN DERIVATIVE; CYTOTOXIC AGENT; HYDROGEN PEROXIDE; METHIONINE; PHENYLENEDIAMINE; PLATINUM DICHLORO(1,2 PHENYLENEDIAMINE); PLATINUM DICHLORO(2 AMINOMETHYLANILINE); PLATINUM DICHLORO[1,2 BIS(AMINOMETHYL)BENZENE]; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER INHIBITION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG STABILITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION;

EID: 0041023879     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-0134(95)00161-1     Document Type: Article

References (29)

1. T. A. Connors, M. Jones, W. C. J. Ross, P. D. Braddock, A. R. Khokhar, and M. L. Tobe, Chem. Biol. Interactions 5, 415 (1972).
2. G. R. Gale, L. M. Loretta, M. Atkins, E. M. Walker, A. B. Smith, and S. J. Meischen, Proc. Soc. Exp. Biol. Med. 142, 1349 (1973).
3. S. J. Meischen, G. R. Gale, L. M. Lake, C. J. Frangakis, M. G. Rosenblum, E. M. Walker, L. M. Atkins, and A. B. Smith, J. Natl. Cancer Inst. 57, 841 (1976).
4. J. H. Burchenal, K. Kalaher, K. Dew, and L. Lokys, Cancer Treat. Rep. 63, 1493 (1979).
5. C. Hansch, B. H. Venger, and A. Panthananickal, J. Med. Chem. 23, 459 (1980).
6. R. K. Clark and A. A. Pessolano, J. Am. Chem. Soc. 80, 1657 (1958).
7. G. W. H. Cheeseman, J. Chem. Soc. 1170 (1962).
8. E. F. Elslager, D. F. Worth, N. F. Haley, and S. C. Perricone, J. Heterocyclic Chem. 5, 609 (1968).
9. R. Köckerbauer and P. J. Bednarski, J. Pharm. Sci. 84, 819 (1995).
10. Z. Y. Jiang, A. C. Wollard, and S. P. Wolff, FEBS Lett. 268, 69 (1990).
11. H. E. Aebi, in Methods of Enzymatic Analysis. Enzymes 1: Oxidoreductases and Transferases, H. U. Bergmeyer, J. Bergmeyer, and M. Graßl, Eds., VCH, Weinheim, 1983, p. 277.
12. P. J. Bednarski, E. Ehrensperger, H. Schönenberger, and T. Burgemeister, Inorg. Chem. 30, 3015 (1991).
13. P. J. Bednarski and B. Trümbach, Trans. Met. Chem. (London) 19, 513 (1994).
14. P. J. Bednarski, Biochem. Pharmacol. 43, 2609 (1992).
15. T. Spruß, G. Bernhardt, E. Schickaneder, and H. Schönenberger, J. Cancer Res. Clin. Oncol. 117, 435 (1991).
16. T. G. Appleton, J. W. Connor, and J. R. Hall, Inorg. Chem. 27, 130 (1988).
17. R. E. Norman, J. D. Ranford, and P. J. Sadler, Inorg. Chem. 31, 877 (1992).
18. P. J. Bednarski, J. Inorg. Biochem. 60, 1-19 (1995).
19. S. J. Lippard, in Bioinorganic Chemistry, I. Bertini, H. B. Gray, S. J. Lippard, and J. S. Valentine, Eds., University Science Books, Mill Valley, CA, 1994, pp. 522-583.
20. F. Feigl and M. Fürth, Monatsch. 48, 445 (1927).
21. A. L. Balch and R. H. Holm, J. Amer. Chem. Soc. 88, 5201 (1966).
22. G. Swartz Hall and R. H. Soderberg, Inorg. Chem. 7, 2300 (1968).
23. T. J. Monks, R. P. Hanzlik, G. M. Cohen, D. Ross, and D. G. Graham, Toxicol. Appl. Pharmacol. 112, 2 (1992).
24. D. E. Levin, M. Hollstein, M. F. Christman, E. A. Schwiers, and B. N. Ames, Proc. Natl. Acad. Sci. 79, 7445 (1982).
25. P. C. Dedon and R. F. Borch, Biochem. Pharmacol. 36, 1955 (1987).
26. S. K. Mauldin, M. Plescia, F. A. Richard, S. D. Wyrick, R. D. Voyksner, and S. G. Chaney, Biochem. Pharmacol. 37, 3321 (1988).
27. P. J. Bednarski, B. Trümbach, N. A. Kratochwil, and H. Schönenberger, J. Med. Chem. 35, 4479 (1992).
28. P. T. Daley-Yates and D. C. H. McBrien, Biochem. Pharmacol. 33, 3063 (1984).
29. K. J. Barnham, U. Frey, P. del Socorro Murdoch, J. D. Ranford, and P. J. Sadler, J. Amer. Chem. Soc. 116, 11175 (1994).